Regeneron Pharmaceuticals, Inc.

Gradient Investments LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/8/2026

Shares

896

Value ($000)

692

Weight

0.0%

2019 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/8/2026	692	0.0%	896	12/31/2025
2024 Q2	7/18/2024	9	0.0%	9	6/30/2024
2024 Q1	4/23/2024	10	0.0%	10	3/31/2024
2023 Q4	1/18/2024	14	0.0%	16	12/31/2023
2023 Q3	10/27/2023	13	0.0%	16	9/30/2023
2023 Q2	7/11/2023	12	0.0%	17	6/30/2023
2023 Q1	4/17/2023	11	0.0%	13	3/31/2023
2022 Q4	1/10/2023	10	0.0%	14	12/31/2022
2022 Q3	10/14/2022	10	0.0%	14	9/30/2022
2022 Q2	7/11/2022	8	0.0%	14	6/30/2022
2022 Q1	5/26/2022	8	0.0%	11	3/31/2022
2021 Q4	1/12/2022	7	0.0%	11	12/31/2021
2021 Q3	10/18/2021	7	0.0%	11	9/30/2021
2021 Q2	7/12/2021	6	0.0%	11	6/30/2021
2021 Q1	4/21/2021	5	0.0%	11	3/31/2021
2020 Q4	1/8/2021	7	0.0%	12	12/31/2020
2020 Q3	10/6/2020	7	0.0%	12	9/30/2020
2020 Q2	7/10/2020	4	0.0%	7	6/30/2020
2020 Q1	4/7/2020	3	0.0%	6	3/31/2020
2019 Q4	1/15/2020	2	0.0%	6	12/31/2019